Article: Genome-wide association study identifies breast cancer risk variant at 10q21.2: Results from the asia breast cancer consortium

This research was supported in part by US National Institutes of Health grants R01CA124558, R01CA064277, R37CA070867, R01CA090899 and R01CA100374, as well as Ingram Professorship and Research Reward funds awarded to W.Z.; R01CA118229, R01CA092585, and Department of Defense (DOD) Idea Award BC011118 awarded to X.-O.S.; and R01CA122756 and DOD Idea Award BC050791 awarded to Q. C. Participating studies (principal investigator, grant support) in the consortium are as follows: the Shanghai Breast Cancer Study (W.Z., R01CA064277), the Shanghai Breast Cancer Survival Study (X.-O.S., R01CA118229), the Shanghai Endometrial Cancer Study (X.-O.S., R01CA092585, contributed only controls to the consortium), the Seoul Breast Cancer Study [D. K., Basic Research Laboratory (BRL) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, 2011-0001564], the Korean Hereditary Breast Cancer Study/Korean Genome and Epidemiology Study (S.-W.K., the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea, 1020350), the Tianjin Study (K. C., the National Natural Science Foundation of China Grant No. 30771844), the Nanjing Study (H. S., 09KJA330001, Jiangsu, China), the Taiwan Biobank Study (C.-Y.S., DOH97-01), the Hong Kong Study (U.S.K., Research Grant Council, Hong Kong SAR, China, HKU 7520/05M and 76730M), the Guangzhou Breast Cancer Study (Z.R., the National Natural Science Foundation of China, 81072383), the Multiethnic Cohort Study (B. E. H., CA063464; L. K., CA054281; and C. H., CA132839), the Nagano Breast Cancer Study (S. T., Grants-in-Aid for the Third Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan, for Scientific Research on Priority Areas, 17015049 and for Scientific Research on Innovative Areas, 221S0001, from the Ministry of Education, Culture, Sports, Science, and Technology of Japan) and the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (K. T., Grants-in-Aid for Scientific Research on Priority Areas, 17015052, from the Ministry of Education, Culture, Sports, Science, and Technology of Japan H. T., Grants-in-Aid for the Third Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan, H20-002). Sample preparation and genotyping assays at Vanderbilt were conducted at the Survey and Biospecimen Shared Resources and Vanderbilt Microarray Shared Resource, which are supported in part by Vanderbilt-Ingram Cancer Center (P30 CA068485).